Figure 4.
Tumor targeting of known sites of disease. Image obtained 46 hours after the administration of 111In (5 mCi)/90Y (15 mCi/m2)–DOTA-biotin. Gamma camera whole-body scans of patient no. 3 (anterior view on left and posterior view on right) obtained 46 hours after infusion of 111In/90Y-DOTA-biotin. Arrows are showing radionuclide localization to known sites of tumor involvement.